Pharmaceutical Sciences
Identification and development of potential antiviral drug molecules against SARS-CoV-2
Development of some mammalian cell based models to screen potent leads that might inhibit viral infection
Machine learning based approach to optimize novel small molecules towards development of novel therapeutics against COVID19
Optimize ultraviolet irradiation of an infected patient's blood to improve the immunity
Re-purposing of FDA drugs and exploitation of ancient Ayurvedic knowledge to discover novel inhibitors to block coronavirus propagation
Preparation of Disease management Manual for Primary Health Centers (PHCs) and Hospitals
Targeting n3CLPro main protease, spike surface protein of COVID-19 In silico screening of FDA approved compounds
Designing virus-like particles as vaccine candidates against nCoV-19 Proposed express M (Membrane), N (Nucleocapsid), E (Envelope) and S (Spike) proteins of nCoV-19 simultaneously in HEK293 cells for generating virus-like particle
Computational prediction of possible nCoV-19 structural proteins inhibitors from Azadirachta indica (Neem) Five potential compounds screened for CL-3 protease protein of nCov19
Creating candidate vaccine against the COVID-19
Pages
